Gabelli & Co Investment Advisers’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-83,267	Closed	-$3.6M	–	196
2015 Q3	$3.6M	Buy	+83,267	New	+$3.51M	0.51%	40

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Gabelli & Co Investment Advisers's WX Position: Q4 2015 in Review

Gabelli & Co Investment Advisers sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 83,267 shares — an estimated $3.6M sold.

Gabelli & Co Investment Advisers first reported a position in WX in Q3 2015 and held it in 1 quarter. The position peaked at $3.6M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Gabelli & Co Investment Advisers reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 83,267 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $3.6M.
Gabelli & Co Investment Advisers first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2015 and held it in 1 quarter.
Gabelli & Co Investment Advisers's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $3.6M in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2015, filed 5 Feb 2016.